NO. | Beijing Time (UTC+8) | Type | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|---|
1 | 10:15-10:30 | Oral Presentation |
A chlorin e6 derivative-mediated photodynamic therapy for mild to moderate acne: A prospective, single-blind, randomized, split-face controlled study |
Haiyan Zhang | Shanghai Skin Disease Hospital |
2 | 10:30-10:45 | Oral Presentation |
Photodynamic Strategies for Combating Bacterial Biofilm-Associated Infections |
Kate Blanco | University of São Paulo |
3 | 10:45-11:00 | Oral Presentation |
Organ transplant recipients’ attitudes toward photodynamic therapy for actinic keratosis: A survey from Imperial College NHS Trust dermatology transplant clinic |
Pawel Bogucki | Imperial College Hospitals, London |
4 | 11:00-11:15 | Oral Presentation |
Photodynamic combined surgery for the treatment of disfiguring diseases of the head and face |
Wenbo Bu | Institute of Dermatology |
5 | 11:15-11:30 | Oral Presentation |
Combining photodynamic therapy with low-temperature radiofrequency to treat periungual warts |
Chen Mingyi | Sichuan Provincial People's Hospital |
6 | 11:30-11:45 | Oral Presentation |
Clinical Practice of Surgery Combined with Photodynamic Therapy for Extramammary Paget's Disease |
Baixin Li | Department of Dermatology, Xiangya Hospital, Central South University |
7 | 11:45-12:00 | Oral Presentation |
Curcumin targets YAP1 to promote mitochondrial function and autophagy and its protective effects against UVB induced photodamage in vitro and in vivo |
Quan Chen | Guangzhou Institute of Dermatology |
NO. | Beijing Time (UTC+8) | Type | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|---|
1 | 13:45-14:02 | Oral Presentation |
Efficacy and safety of photodynamic therapy mediatied by 5-aminolevulinic acid for the treatment of cervical intraepithelial neoplasia 3(CIN 3): A single-center, prospective, cohort study |
Zhangxin Wu | Peking University Third Hospital |
2 | 14:02-14:19 | Oral Presentation |
The effectiveness of photodynamic therapy using 5-aminolevulinic acid in the patients with cervical intraepithelial neoplasia high-grade categories (CIN III) |
Egor Slovokhodov | Central Clinical Hospital of the Administrative directorate of the President of the Russian Federation |
3 | 14:19-14:36 | Oral Presentation |
Efficacy of Photodynamic Therapy as an Adjunctive Treatment for Cervical HSIL Patients with Positive Margins after LEEP |
Liying Gu | Department of Obstetrics & Gynecology, Renji Hospital, School of medicine, Shanghai Jiaotong University |
4 | 14:36-14:53 | Oral Presentation |
Gynecological and obstetrical outcomes of phase I /II study of photodynamic therapy using talaporfin sodium (Laserphyrin) and diode laser (L-PDT) for Cervical Intraepithelial Neoplasia. |
Masaru Sakamoto | Dept. of Gynecology, Sasaki Foundation Kyoundo Hospital, Tokyo, Japan |
5 | 14:53-15:10 | Oral Presentation |
A Multicenter, Phase II Study of Photodynamic Therapy Using Talaporfin Sodium for Cervical Intraepithelial Neoplasia |
Hirotake Murakami | Hamamatsu University School of Medicine |
6 | 15:10-15:27 | Oral Presentation |
Comparison of the efficacy of photodynamic combined laser therapy with cervical circumferential resection for high-grade squamous intraepithelial lesions of the cervix |
Mengting Chen | minhang hospital |
7 | 15:27-15:44 | Oral Presentation |
A pilot study of repeated 5-aminolevulinic acid photodynamic therapy for cervical intraepithelial neoplasia by a newly developed intravaginal irradiation system |
Masato Kita | Kansai Medical University |